MD
Pediatrix Medical Group Inc.
$21.56
+$0.30(+1.41%)
65
Overall
80
Value
60
Tech
55
Quality
Market Cap
$1.96B
Volume
711.14K
52W Range
$11.84 - $24.99
Target Price
$23.17
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $3.2B | $3.5B | $3.5B | $1.8B | $1.7B | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B | ||
| Total Revenue | $3.2B | $3.5B | $3.5B | $1.8B | $1.7B | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | $1.3B | $1.4B | $1.5B | $1.6B | $1.6B | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $3.2B | $3.5B | -- | $1.8B | $449.3M | $513.2M | $467.0M | $2.0B | $2.0B | $1.9B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-2.6B | $-3.0B | $-3.0B | $1.6B | $1.6B | $1.7B | $267.0M | $2.0B | $2.1B | $1.7B | ||
| Research & Development | -- | -- | -- | -- | -- | -- | -- | -- | $32.2M | $21.8M | ||
| Research Expense | -- | -- | -- | -- | -- | -- | -- | -- | $32.2M | -- | ||
| Selling, General & Administrative | $372.6M | $417.1M | $403.9M | $244.5M | $248.9M | $263.4M | $231.4M | $263.7M | $238.4M | $240.8M | ||
| General & Administrative Expenses | $372.6M | $417.1M | $403.9M | $244.5M | $248.9M | $263.4M | $231.4M | $263.7M | $238.4M | $240.8M | ||
| Salaries & Wages | $-34.0M | $-29.6M | $-37.9M | -- | -- | -- | $14.4M | -- | -- | -- | ||
| Depreciation & Amortization | $89.3M | $102.9M | $83.8M | $25.9M | $28.4M | $32.1M | $35.6M | -- | -- | -- | ||
| Depreciation & Amortization | $89.3M | $102.9M | $83.8M | $25.9M | $28.4M | $32.1M | $35.6M | -- | -- | -- | ||
| Amortization | $-60.3M | $-68.9M | $-54.5M | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B | $1.2B | -- | ||
| Other Operating Expenses | $2.1B | $2.5B | $2.5B | $-1.3B | $-1.3B | $-1.4B | $-800.0K | $2.0B | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $571.7M | $-3.0B | $-3.0B | $171.8M | $98.1M | $202.9M | $172.7M | $7.3M | $-68.7M | $208.8M | ||
| EBITDA | $671.0M | $593.4M | $532.3M | $209.3M | $146.1M | $236.1M | $158.5M | $31.1M | $-27.4M | $275.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $63.1M | $74.6M | $88.8M | $118.9M | $110.5M | $68.7M | $39.7M | $42.1M | $40.7M | $36.0M | ||
| Intinc | $-57.9M | $-69.7M | $-76.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-61.1M | $-70.6M | $-83.6M | $-118.9M | $-110.5M | $-68.7M | $-39.7M | $-42.1M | $-40.7M | $-36.0M | ||
| Gain on Sale of Securities | -- | -- | -- | $3.7M | $17.9M | $11.4M | $-1.4M | $5.9M | $6.9M | $41.6M | ||
| Other Income/Expense | $-3.2M | $-3.5B | $-3.5B | $-6.0M | $-19.5M | $8.5M | $-78.9M | $-7.9M | $28.2M | $-45.3M | ||
| Other Special Charges | $22.0M | $3.5B | $3.5B | $-113.0M | $-91.0M | $-14.5M | $-57.0M | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-329.7M | $-69.0K | -- | $60.9M | $73.8M | $22.1M | $27.3M | $2.2M | $64.3M | $22.3M | ||
| Special Income Charges | $13.2M | $23.9M | $52.3M | $-60.9M | $-73.8M | $-22.1M | $-27.3M | $-170.5M | $-214.9M | $-22.3M | ||
| Impairment of Capital Assets | -- | -- | -- | $1.4B | -- | -- | -- | $168.3M | $150.6M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $576.9M | $485.0M | $443.9M | $177.7M | $117.6M | $203.9M | $121.1M | $-6.3M | $-60.6M | $252.4M | ||
| Pre-Tax Income | $513.8M | $410.4M | $355.1M | $58.8M | $7.1M | $135.2M | $81.4M | $-48.4M | $-101.3M | $216.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $189.2M | $90.0M | $96.5M | $16.6M | $16.7M | $27.2M | $18.8M | $12.0M | $-2.3M | $51.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $324.9M | $320.4M | $527.2M | $-1.5B | $-796.5M | $131.0M | $66.3M | $-60.4M | $-99.1M | $165.4M | ||
| Net Income (Continuing Operations) | $324.9M | $320.4M | $527.2M | $-1.5B | $-796.5M | $131.0M | $62.6M | $-60.4M | $-99.1M | $165.4M | ||
| Net Income (Discontinued Operations) | $324.9M | $320.4M | $527.2M | $-1.5B | $-796.5M | $131.0M | $66.3M | $-60.4M | $-99.1M | $165.4M | ||
| Net Income (Common Stockholders) | $324.9M | $320.4M | $527.2M | $1.1B | $-796.5M | $131.0M | $66.3M | $-60.4M | $-99.1M | $165.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $236.5M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-2.6B | $-3.0B | $-3.0B | $1.6B | $1.6B | $1.7B | $1.8B | $2.0B | $2.1B | $1.7B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $92.4M | $92.4M | $91.1M | $83.5M | $83.4M | $84.8M | $83.5M | $82.2M | $83.3M | $84.1M | ||
| Average Shares Outstanding (Diluted) | $93.1M | $93.0M | $91.6M | $83.5M | $83.4M | $85.8M | $84.1M | $82.2M | $83.3M | $85.3M | ||
| Shares Outstanding | $93.8M | $93.8M | $87.9M | $84.3M | $85.6M | $86.5M | $83.0M | $84.1M | $85.8M | $83.0M | ||
| Basic EPS | $3.52 | $3.47 | $2.95 | $-35.88 | $-19.1 | $3.08 | $1.58 | $-0.73 | $-1.19 | $1.97 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-31.72 | $-9.66 | $2.81 | $1.54 | $1.46 | $-2.38 | $1.97 | ||
| Diluted EPS | $3.49 | $3.45 | $2.93 | $-35.88 | $-19.1 | $3.06 | $1.58 | $-0.73 | $-1.19 | $1.94 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-31.72 | $-9.66 | $2.79 | $1.53 | $1.46 | $-2.38 | $1.94 | ||
| OTHER METRICS | ||||||||||||
| Allowances For Construction | -- | -- | -- | -- | -- | -- | -- | $36.2M | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | -- | $-4.16 | $-9.44 | $0.27 | $0.04 | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $21.8M | ||
| Diluted Discontinuous Operations | -- | -- | -- | $-4.16 | $-9.44 | $0.27 | $0.05 | -- | -- | -- | ||
| Earnings from equity interest | $3.2M | $952.0K | $6.8M | $2.3M | $1.6M | $1.9M | $1.7M | $2.1M | $2.3M | $3.6M | ||
| Earnings From Equity Interest Net Of Tax | $3.2M | $952.0K | $6.8M | $2.3M | $1.6M | $1.9M | $1.7M | $2.1M | $2.3M | $3.6M | ||
| Gain On Sale Of Business | -- | -- | -- | -- | -- | -- | -- | -- | $-9.7M | -- | ||
| Gain On Sale Of P P E | $4.1M | -- | -- | -- | -- | $-7.3M | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | $10.0M | $20.1M | -- | -- | -- | -- | -- | -- | ||
| Insurance And Claims | -- | -- | -- | $22.7M | $24.6M | $24.2M | $37.0M | -- | -- | -- | ||
| Minority Interests | $318.0K | -- | -- | $1.5B | $747.7M | $27.0K | $4.0K | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | $10.0M | $-1.5B | $-786.9M | $22.9M | $3.8M | -- | -- | -- | ||
| Net Income Extraordinary | -- | -- | $258.6M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | $-1.5B | $-786.9M | $22.9M | $3.8M | -- | -- | -- | ||
| Other Gand A | $372.6M | $417.1M | $403.9M | $244.5M | $248.9M | $263.4M | $231.4M | $263.7M | $238.4M | $240.8M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | $27.8M | -- | ||
| Other Taxes | $61.8M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $372.6M | $417.1M | $403.9M | -- | -- | -- | -- | $36.2M | -- | -- | ||
| Othspecchg | $-13.2M | $-23.9M | $-52.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-329.7M | $-69.0K | -- | $60.9M | $73.8M | $22.1M | $27.3M | $2.2M | $64.3M | $22.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MD | $21.56 | +1.4% | 711.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pediatrix Medical Group Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW